書籍詳細

―剖検例の検討―

P.6 掲載の参考文献

• 1) 長澤俊彦:血管炎の臨床的概念と分類. 日本臨床 43(10):40-43, 1985.

• 2) 柴田尚武, 森 和夫:神経系血管炎. 日本臨床 43(10):132-138, 1985.

• 3) 武田善樹, 木崎智彦, 前田裕己:血管炎の病理形態学的分類. 日本臨床 43(10):14-17, 1985.

P.15 掲載の参考文献

• 1) Winterbauer RH, et al:Diffuse pulmonary injury associated with gold treatment. N. Eng. J. Med. 294:919-921, 1976.

• 2) Yousem SA, et al:Lung biopsy in rheumatoid arthritis. Am. Rev. Respir. Dis. 131:770-777, 1985.
  pubmed

• 3) 池田 俊・他:"Gold lung"の気管支肺胞洗浄液中のT細胞増加とリンホカインについて. 日胸疾患会誌 24:1258-1265, 1986.

• 4) 本間智子・他:金剤使用中に間質性肺炎を発症した慢性関節リウマチの2例. 中部リウマチ 21:103-105, 1990.

• 5) 青柴和徹・他:Gold lungの1症例と文献的考察-Gold lungの線維化に関する臨床的検討. 日胸疾患会誌 28:336-343, 1990.

• 6) 田村 久・他:金剤使用中に発症した間質性肺炎の検討. 臨放 35:217-223, 1990.

• 7) 北原多喜:パルス療法が奏効した金製剤による間質性肺炎の1例. 日胸 50:410-415, 1991.

• 8) 梅木茂宣・他:経口金製剤誘発間質性肺炎例. 日胸疾患会誌 29:885-892, 1991.

• 9) 津田美奈子・他:金製剤使用中に発症した間質性肺炎の一症例. 中部リウマチ 23:164-177, 1992.

• 10) 白石素公・他:Gold pneumonitis の1症例. 呼吸 11:1183-1188, 1992.
  Medical*Online

• 11) 二宮涼子・他:金製剤使用中に間質性肺炎を併発した尋常性天疱瘡の1例. 臨皮 46:1017-1021, 1992.

• 12) 坂東政司・他:少量金剤投与にてリンパ球刺激試験が陽性を呈した金製剤肺臓炎と思われる1例. 日胸疾患会誌 30:128-132, 1992.

• 13) 松村栄久・他:気管支肺胞洗浄液中リンパ球で金に対するリンパ球刺激試験陽性を証明した金肺炎の1例. 日胸疾患会誌 30:472-477, 1992.

• 14) Evans RB, et al:Gold lung:recent developments in pathogenesis, diagnosis, and therapy. Semin. Arthritis. Rheum. 16:196-205, 1987.
  pubmed

• 15) 日高利彦・他:若年性結節性多発動脈炎との鑑別が困難であった若年発症悪性関節リウマチの1剖検例. リウマチ 32:318-326, 1992.

P.21 掲載の参考文献

• 1) 新名正由・他:各種関節疾患における関節液中 Type-II-Procollagen Carboxypeptide測定の意義. リウマチ 32:453-460, 1992.

• 2) Maurice H, et al:Synovial chondromatosis. J. Bone Joint Surg. 70-B:807-811, 1988.

• 3) Shinmei M, et al:Joint fluid carboxy-terminal type II procollagen peptide as a marker of cartilage collagen biosynthesis. Osteoarthritis Cart. 1:121-128, 1993.

• 4) 帝人株式会社, 社内資料.

• 5) Ryan LM, et al:Predominance of type II collagen in synovial chondromatosis. Clin. Orthop. 168:173-177, 1982.
  pubmed

P.28 掲載の参考文献

• 1) 五十嵐敢, 渋谷知加子, 前田恵治・他:皮膚筋炎における急速進行性線維化性肺胞炎の検討. 第29回日本胸部疾患学会総会. p. 337, 1989.

• 2) 高林克日己, 倉沢和宏, 杉山隆夫・他:皮膚筋炎, 多発性筋炎にみられる急性びまん性肺疾患の臨床像と予後. 日臨免疫会誌 14(2):122-130, 1991.

• 3) 奥田恭章, 高杉 潔, 今井淳子・他:皮膚筋炎に伴う急速進行型間質性肺炎の2例-その臨床像と免疫異常について. リウマチ 33(4):293-301, 1993.

• 4) 佐伯敬子, 鈴木栄一, 渡邊 武・他:多発性筋炎/皮膚筋炎に伴った間質性肺炎の予後に関する検討. リウマチ 34(1):16-21, 1994.

• 5) Fudman E J and Schnitzer T J:Dermatomyositis without creatine kinase elevation. A poor prognostic sign. Am. J. Med. 80:329-332, 1986.
  pubmed

• 6) Tazelaar H D, Viggiano R W, Pickersgill J, et al:Interstitial lung disease in polymyositis and dermatomyositis. Am. Rev. Respir. Dis. 141:727-733, 1990.
  pubmed

P.34 掲載の参考文献

• 1) Bardor S, et al:Risk of cancer in patients with dermatomyositis or polymyositis. A population based study. N. Engl. J. Med. 326:363-367, 1992.
  pubmed

• 2) Hirano A, et al:Malignancy and interstitial pneumonitis as fatal complications in dermatomyositis. J. Dermatol. 19:153-160, 1992.

• 3) 夏目 妙・他:胃癌を合併した皮膚筋炎. 西日皮膚 52:231-236, 1990.

• 4) Callen JP:Dermatomyositis and malignancy. Clin. Rheum. Dis. 8:369-381, 1982.
  pubmed

• 5) Wong KO:Dermatomyositis and malignancy. A clinical investigation of twenty-three cases in Hong Kong. Brit. J. Derm. 81:544-547, 1969.

• 6) Chan HL:Dermatomyositis and cancer in Singapore. Int. J. Dematol. 24:447-450, 1985.

• 7) 荻野隆光・他:悪性腫瘍を伴った皮膚筋炎患者の麻酔経験. 麻酔 33:198-203, 1984.
  Medical*Online

• 8) Barns BE:Dermatomyositis and malignancy. A review of the literature. Ann. Intern. Med. 84:68-76, 1976.

• 9) Richardson JB, et al:Dermatomyositis and malignancy. Med. Clin. North. Am. 73:1211-1220, 1989.
  pubmed

• 10) Stone OJ, et al:Dermatomyositis/Polymyositis associated with internal malignancy. A consequence of how neoplasms alter generalized extracellular matrix in the host. Med. Hypoth. 41:48-51, 1993.

P.42 掲載の参考文献

• 1) 七川歓次, 前田 晃, 広瀬俊一, 山本純己:慢性関節リウマチ患者の実態に関する調査研究, 昭和63年度厚生科学研究費補助金(特別研究事業)事業実績報告書, 1990.

• 2) 塩澤俊一:自己免疫疾患はなぜ慢性疾患なのか-慢性関節リウマチの病因について-. 免疫薬理 12(3):301-309, 1994.

• 3) Shiozawa S and Shiozawa K:A review of the histopathological evidence on the pathogenesis of cartilage destruction in rheumatoid arthritis. Scand. J. Rheumatol. 74(Suppl. ):65-72, 1988.

• 4) Shiozawa S and Tokuhisa T:Contribution of synovial mesenchymal cells to the pathogenesis of rheumatoid arthritis. Sem. Arthritis Rheum. 21:267-273, 1992.

• 5) Shiozawa S, Tanaka Y, Fujita T and Tokuhisa T:Destructive arthritis without lymphocyte infiltration in H2-c-fos transgenic mice. J. Immunol. 148:3100-3104, 1992.
  pubmed

• 6) Kuroki Y, Shiozawa S, Yoshihara R and Hotta T:The contribution of human c-fos DNA to cultured synovial cells:A transfection study. J. Rheumatol. 20:422-428, 1993.

• 7) Kuroki Y, Shiozawa S, Sugimoto T and Fujita T:Constitutive expression of c-fos gene inhibits type I collagen synthesis in transfected osteoblasts. Biochem. Biophys. Res. Commun. 182:1389-1394, 1992.

• 8) Kuroki Y, Shiozawa S, Sugimoto T, Kanatani M, Kaji H, Miyauchi A and Chihara K:Constitutive c-fos expression in osteoblastic MC3T3-E1 cells stimulates osteoclast maturation and osteoclastic bone resorption. Clin. Exp. Immunol. 95:536-539, 1994.

• 9) Shiozawa S and Kuroki Y:Osteoporosis in rheumatoid arthritis:A molecular biological aspect of connective tissue gene activation. Tohoku J. Exp. Med. 173:189-198, 19994.

• 10) Shiozawa K, Shiozawa S, Shimizu S and Fujita T:Fibronectin on the surface of articular cartilage in rheumatoid arthritis. Arthritis Rheum. 27:615-622, 1984.

• 11) Shiozawa S, Yoshihara R, Kuroki Y, Fujita T, Shiozawa K and Imura S:Pathogenic importance of fibronectin in the superficial region of articular cartilage as a local factor for the induction of pannus extension on rheumatoid articular cartilage. Ann. Rheum. Dis. 51:869-873, 1992.
  pubmed

• 12) Miyauchi A, Kuroki Y, Fukase M, Fujita T, Chihara K and Shiozawa S:Persistent expression of proto-oncogene c-fos stimulates osteoclast differentiation. Biochem. Biophys. Res. Commun. 205:1547-1555, 1994.
  pubmed

• 13) Hino K, Shiozawa S, Kuroki Y, Ishikawa H, Shiozawa K, Sekiguchi K, Hirano H, Sakashita E, Miyashita K and Chihara K:EDA-containing fibronectin is synthesyzed from rheumatoid synovial fibroblast-like cells. Arthritis Rheum. 38:678-683, 1995.
  pubmed

• 14) Kuroki Y, Shiozawa S, Kano J and Chihara K:Competition between c-fos and vitamin D3 in collagen synthesis in osteoblastic MC3T3-E1 cells. J. Cell. Physiol. 164:459-464, 1995.

P.49 掲載の参考文献

• 1) Harris ED Jr:Rheumatoid arthritis;pathophysiology and implications for therapy. N. Engl. J. Med. 322:1277-1289, 1990.
  pubmed

• 2) Feldmann M, et al:Analysis of T cell clones in rheumatoid arthritis. Springer Semin. Immunopathol. 10:157-167, 1988.
  pubmed

• 3) van Boxel JA, et al:Predominanttly T-cell infiltrate in rheumatoid synovial membranes. N. Engl. J. Med. 293:517-520, 1975.
  pubmed

• 4) Todd JAH, et al:A molecular basis for MHC class II associated autoimmunity. Science 240:1003-1009, 1988.

• 5) Horneff G, et al:Treatment of rheumatoid arthritis with an anti-CD4 monoclonal antibody. Arthritis Rheum. 34:129-140, 1991.
  pubmed

• 6) Isaacs JD, et al:Humanaised monoclonal antibody therapy for rheumatoid arthritis. Lancet ii:748-752, 1992.

• 7) Kakimoto K, et al:Isolation of T cell line capable of protecting mice ageinst collagen-induced arthritis. J. Immunol. 140:78-83, 1988.
  pubmed

• 8) Chiocchia G, et al:Therapy against murine collagen-induced arthritis with T cell receptor V β-specific antibodies. Eur. J. Immunol. 21:2899-2905, 1991.

• 9) Paliard X, et al:Evidence for the effects of a superantigen in rheumatiod arthritis. Science 253:325-329, 1991.

• 10) Uematsu Y, et al:The T-cell-receptor repatoire in the synovial fluid of a patient with rheumatoid arthritis is polyclonal. Proc. Natl. Acad. Sci. USA 88:8534-8538, 1991.

• 11) Howell MD, et al:Limited T-cell receptor β-chain heterogeneity among interleukin 2 receptor-positive synovisl T cells sugests a role for superantigen in rheumatoid arthritis. Proc. Natl. Acad. Sci. USA 88:10921-10925, 1991.

• 12) Williams WV, et al:Restricted heterogeneity of T cell receptor transcripts in rheumatoid synovium. J. Clin. Invest. 90:326-333, 1992.
  pubmed

• 13) Keffer J, et al:Transgenic mice expressing human tumor necrosis factor:a predictive genetic model of arthritis. EMBO J. 10:4025-4031, 1991.
  pubmed

• 14) Iwakura Y, et al:Induction of inflammatory arthropathy resembling rheumatoid arthritis in mice transgenic for HTLV-I. Science 253:1026-1028, 1991.
  pubmed

• 15) Saeki Y, et al:Transfer of multiple sclerosis into severe combined immunodefiency mice by mononuclear cells from cerebrospinal fluid of the patients. Proc. Natl. Acad. Sci. USA 89:6157-6161, 1992.

• 16) Mima T, et al:Transfer of rheumatoid arthritis into severe combined immunodeficient mice;The pathogenetic implications of T cell populations oligoclonally expanding in the rheumatoid joints. J. Clin. Invest. 96, 1995. (in press)